Mukka Proteins Limited
Mukka Proteins' credit rating for long-term bank facilities has been downgraded by CARE Ratings to CARE BBB-; Negative. This downgrade is attributed to the company's elongated working capital cycle and high inventory levels, impacting its liquidity buffer.
May 26 2026 17:27:26
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Credit Rating
CARE Ratings has downgraded Mukka Proteins' credit ratings for its long-term bank facilities to BBB- Negative and short-term debt to A3. This action primarily stems from a continued elongation of the company's working capital cycle and deteriorated debt coverage indicators.
May 26 2026 17:26:18
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Mukka Proteins reported strong FY26 performance, with revenue growing 44% YoY to Rs.1,449.5 crore and PAT increasing 18.7% YoY to Rs.57.1 crore. The company is also undertaking strategic expansions in Oman and Sri Lanka and secured a waste management contract.
May 16 2026 19:53:29
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Acquisition
Mukka Proteins Ltd approved the incorporation of 'MPL FC HRC JV', a new partnership firm. This venture, with a 51% capital contribution, will focus on animal waste treatment and disposal, executing a work order from the company's Joint Venture.
May 15 2026 17:40:38
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Acquisition
Mukka Proteins Ltd's board approved the incorporation of Lanka Bio Proteins Private Limited in Sri Lanka. The company will invest Rs.2.5 crore for a 49% stake to expand its international marine products operations, with completion by December 2026.
May 15 2026 17:38:43
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Raising of Funds
Mukka Proteins' Board approved raising up to Rs. 50 crore through secured, rated, listed Non-Convertible Debentures via private placement. These debentures will carry a 12% annual coupon and have a 15-month tenure.
May 15 2026 17:29:36
Mukka Proteins Ltd - 544135 - Board Meeting Outcome for Intimation Of The Outcome Of Board Meeting Held On 15Th May 2026.
Mukka Proteins' board approved Q4 FY26 cons. financial results, reporting ₹367.92 cr revenue and ₹20.62 cr net profit. Additionally, they approved raising ₹75 cr through debentures, a ₹2.55 lakh investment for a 51% stake in a new JV, and a ₹2.5 cr investment for a 49% stake in a Sri Lankan entity to expand operations.
May 15 2026 17:02:05
Mukka Proteins Ltd - 544135 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 And Consider Raising Of Funds By Way Of Issuance Of NCD''s.
Mukka Proteins' Board of Directors is scheduled to meet on May 15, 2026. The agenda includes considering the audited financial results for Q4 FY26 and proposals for raising funds totaling up to Rs. 75 crore through non-convertible debentures via private placement.
May 12 2026 17:06:12
Read More